China National Medicines Corporation Ltd. (SHA:600511)
China flag China · Delayed Price · Currency is CNY
29.23
+0.10 (0.34%)
At close: Feb 6, 2026

SHA:600511 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
51,85250,50049,59245,43646,44240,336
Other Revenue
97.7997.79103.9962.9526.2643.04
51,95050,59749,69645,49946,46940,379
Revenue Growth (YoY)
1.47%1.81%9.22%-2.09%15.08%-9.55%
Cost of Revenue
48,52647,00345,70441,68142,84837,242
Gross Profit
3,4243,5943,9923,8173,6213,136
Selling, General & Admin
1,1701,2671,4301,3921,3551,404
Research & Development
73.1673.7171.26755.7551.87
Other Operating Expenses
144.22126.25109.6946.91120.86105.54
Operating Expenses
1,4281,4891,6201,4981,5661,571
Operating Income
1,9962,1052,3722,3192,0551,566
Interest Expense
-29.55-33.66-31.57-26.88-43.71-56.81
Interest & Investment Income
688.39620.95525.32362.42354.09279.16
Currency Exchange Gain (Loss)
1.941.940.55-1.652.711.57
Other Non Operating Income (Expenses)
12.34-7.04-9.23-43.29-182.24
EBT Excluding Unusual Items
2,6692,6872,8572,6092,3501,792
Gain (Loss) on Sale of Investments
-18.2-18.210.82---
Gain (Loss) on Sale of Assets
0.39-0.190.081.68-0.070.07
Other Unusual Items
-26.7-14.962.8176.995.08125.4
Pretax Income
2,6222,6542,9312,6882,4451,917
Income Tax Expense
510.77523.83596.42559.18516.3408.09
Earnings From Continuing Operations
2,1112,1302,3342,1291,9291,509
Minority Interest in Earnings
-99.63-129.65-188.47-164.65-174.42-126.56
Net Income
2,0112,0002,1461,9641,7541,383
Net Income to Common
2,0112,0002,1461,9641,7541,383
Net Income Growth
-7.11%-6.80%9.26%11.97%26.86%-13.79%
Shares Outstanding (Basic)
755755754755755754
Shares Outstanding (Diluted)
755755754755755754
Shares Change (YoY)
-0.00%0.00%-0.00%-0.00%-0.98%
EPS (Basic)
2.672.652.842.602.321.83
EPS (Diluted)
2.672.652.842.602.321.83
EPS Growth
-7.11%-6.80%9.27%11.97%26.86%-12.94%
Free Cash Flow
567.881,5282,5822,2651,8621,233
Free Cash Flow Per Share
0.752.033.423.002.471.63
Dividend Per Share
0.8000.8000.8540.7820.7000.550
Dividend Growth
-6.32%-6.32%9.21%11.71%27.27%-13.79%
Gross Margin
6.59%7.10%8.03%8.39%7.79%7.77%
Operating Margin
3.84%4.16%4.77%5.10%4.42%3.88%
Profit Margin
3.87%3.95%4.32%4.32%3.77%3.42%
Free Cash Flow Margin
1.09%3.02%5.20%4.98%4.01%3.05%
EBITDA
2,1042,2152,4852,4232,1551,669
EBITDA Margin
4.05%4.38%5.00%5.32%4.64%4.13%
D&A For EBITDA
107.74110.03113.09103.86100.1103.46
EBIT
1,9962,1052,3722,3192,0551,566
EBIT Margin
3.84%4.16%4.77%5.10%4.42%3.88%
Effective Tax Rate
19.48%19.74%20.35%20.80%21.12%21.28%
Revenue as Reported
51,95050,59749,69645,49946,46940,379
Advertising Expenses
-4.746.73.252.253.2
Source: S&P Global Market Intelligence. Standard template. Financial Sources.